Literature DB >> 10666095

Protective roles of endogenous carbon monoxide in neointimal development elicited by arterial injury.

Y Togane1, T Morita, M Suematsu, Y Ishimura, J I Yamazaki, S Katayama.   

Abstract

We reported that carbon monoxide (CO) generated through heme oxygenase (HO) inhibits mitogen-induced proliferation of vascular smooth muscle cells (VSMCs). We report that balloon injury induces HO-1, the stress-inducible isozyme of HO, in VSMCs and inhibits neointimal formation through the action of endogenous CO. Northern blot analysis and immunohistochemistry revealed that HO-1 is markedly induced in the media as early as 1 day after injury, whereas only a little expression was detected in the intact carotid artery. The neointimal proliferative changes were augmented or inhibited by the HO inhibitors or inducer, respectively, and effects of these interventions were not altered by suppression of endogenous nitric oxide (NO), if any. To elucidate the mechanisms by which HO controls the proliferative changes, effects of alterations in the HO reaction were examined by determining angiotensin II-elicited VSMC proliferation in vitro: the HO inducer attenuated and its inhibitor restored the proliferative response to angiotensin II (1 nM and 100 nM). Hemoglobin, a reagent trapping both NO and CO, but not met-hemoglobin, which can capture NO but not CO, augmented the proliferative response. These data suggest that endogenous CO serves as a protective factor that limits the excessive VSMC proliferation associated with vascular diseases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10666095     DOI: 10.1152/ajpheart.2000.278.2.H623

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  20 in total

1.  Comparison of classical and non-classical cardiovascular risk factors influencing the patency of native arteriovenous fistulas after percutaneous transluminal angioplasty therapy among haemodialysis patients.

Authors:  Jiung-Hsiun Liu; Po-Wen Lin; Yao-Lung Liu; Hsin-Hung Lin; Chiu-Ching Huang
Journal:  Postgrad Med J       Date:  2007-08       Impact factor: 2.401

2.  Exhaled carbon monoxide and risk of metabolic syndrome and cardiovascular disease in the community.

Authors:  Susan Cheng; Asya Lyass; Joseph M Massaro; George T O'Connor; John F Keaney; Ramachandran S Vasan
Journal:  Circulation       Date:  2010-09-27       Impact factor: 29.690

Review 3.  Novel therapies for cyclic GMP control of vascular smooth muscle growth.

Authors:  David A Tulis
Journal:  Am J Ther       Date:  2008 Nov-Dec       Impact factor: 2.688

4.  Local administration of carbon monoxide inhibits neointima formation in balloon injured rat carotid arteries.

Authors:  D A Tulis; A N Keswani; K J Peyton; H Wang; A I Schafer; W Durante
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2005-10-03       Impact factor: 1.770

Review 5.  Haeme oxygenase signalling pathway: implications for cardiovascular disease.

Authors:  Laura E Fredenburgh; Allison A Merz; Susan Cheng
Journal:  Eur Heart J       Date:  2015-03-31       Impact factor: 29.983

Review 6.  Heme Oxygenases in Cardiovascular Health and Disease.

Authors:  Anita Ayer; Abolfazl Zarjou; Anupam Agarwal; Roland Stocker
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

Review 7.  [Carbon monoxide--poison or potential therapeutic?].

Authors:  A Hoetzel; R Schmidt
Journal:  Anaesthesist       Date:  2006-10       Impact factor: 1.041

Review 8.  Cardiovascular biomarkers in exhaled breath.

Authors:  Frank S Cikach; Raed A Dweik
Journal:  Prog Cardiovasc Dis       Date:  2012 Jul-Aug       Impact factor: 8.194

9.  HO-1 and CO decrease platelet-derived growth factor-induced vascular smooth muscle cell migration via inhibition of Nox1.

Authors:  Andres I Rodriguez; Archana Gangopadhyay; Eric E Kelley; Patrick J Pagano; Brian S Zuckerbraun; Philip M Bauer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-10-29       Impact factor: 8.311

10.  Anti-atherogenic effect of statins: role of nitric oxide, peroxynitrite and haem oxygenase-1.

Authors:  G Heeba; M E Moselhy; M Hassan; M Khalifa; R Gryglewski; T Malinski
Journal:  Br J Pharmacol       Date:  2009-02-18       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.